278 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
financial and operating results on Thursday, May 2, 2024, at 8:30 AM Eastern Time. Participants may access the conference call live via webcast, or register … passcode and registrant ID that can be used to access the call. A replay of the conference call and webcast will be archived on the Company's website
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
quarter and full year 2023 financial and operating results on Friday, February 2, 2024, at 8:30 AM Eastern Time. Participants may access … -in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the conference call and webcast
8-K
EX-99.1
qn6y7nj162z
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
EX-99.1
6ohz7l
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
SC TO-T/A
EX-99
m1fqj22k
25 Sep 23
Third party tender offer statement (amended)
8:48am
SC TO-T
EX-99
t7dwr80ib i5htd25e
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
EX-99
zho09a90
25 Aug 23
Third party tender offer statement
7:46am
8-K
EX-99.1
n6330 bymj
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
nphk8nm
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:07pm
PX14A6G
sbj ojqup41h29pv2
18 May 23
Letter to shareholders
4:46pm
8-K
EX-99.1
kbg90izv9g5iztyx
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am
DEFA14A
8xkocf6cx
21 Apr 23
Additional proxy soliciting materials
4:03pm
8-K
EX-10.3
4i0 nd09vlttwzsz23
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm